Cytochrome P450-specific human PBPK/PD models for the organophosphorus pesticides: chlorpyrifos and parathion.
暂无分享,去创建一个
Corie A Ellison | J. Olson | James B Knaak | Changxing Ma | James R Olson | J. Knaak | Robert J Foxenberg | Changxing Ma | C. Ellison | R. Foxenberg
[1] B. Alexander,et al. Chlorpyrifos exposure in farm families: Results from the farm family exposure study , 2006, Journal of Exposure Science and Environmental Epidemiology.
[2] Charles Timchalk,et al. An age-dependent physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus insecticide chlorpyrifos in the preweanling rat. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[3] J. Chambers,et al. Age-related differences in parathion and chlorpyrifos toxicity in male rats: target and nontarget esterase sensitivity and cytochrome P450-mediated metabolism. , 1997, Toxicology and applied pharmacology.
[4] K. Jamil,et al. Human serum paraoxonase gene polymorphisms and association with chronic symptoms of pesticide toxicity in Indian farmers , 2009 .
[5] S. Imaoka,et al. A comparison of hepatic cytochrome P450 protein expression between infancy and postinfancy. , 1997, Life sciences.
[6] Dana B Barr,et al. Comparative chlorpyrifos pharmacokinetics via multiple routes of exposure and vehicles of administration in the adult rat. , 2009, Toxicology.
[7] J. Stevens,et al. Human hepatic CYP2B6 developmental expression: the impact of age and genotype. , 2009, Biochemical pharmacology.
[8] M. Hooper,et al. Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos. , 1996, Journal of biochemical toxicology.
[9] Z. Radić,et al. Differentiation of esterases reacting with organophosphorus compounds. , 1993, Chemico-biological interactions.
[10] D. Shih,et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis , 1998, Nature.
[11] J. Chambers,et al. Kinetic parameters of desulfuration and dearylation of parathion and chlorpyrifos by rat liver microsomes. , 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[12] D. Barr,et al. Concentrations of selective metabolites of organophosphorus pesticides in the United States population. , 2005, Environmental research.
[13] E. Testai,et al. CYP-specific bioactivation of four organophosphorothioate pesticides by human liver microsomes. , 2003, Toxicology and applied pharmacology.
[14] G. Tucker,et al. Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver. , 2003, British journal of clinical pharmacology.
[15] H. Mohrenweiser,et al. Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. , 2001, The Journal of pharmacology and experimental therapeutics.
[16] D. Herndon,et al. Fatty infiltration of the liver in severely burned pediatric patients: autopsy findings and clinical implications. , 2001, The Journal of trauma.
[17] B. Ring,et al. Hepatic CYP2B6 Expression: Gender and Ethnic Differences and Relationship to CYP2B6 Genotype and CAR (Constitutive Androstane Receptor) Expression , 2003, Journal of Pharmacology and Experimental Therapeutics.
[18] A. Samii,et al. Human PON1, a biomarker of risk of disease and exposure. , 2010, Chemico-biological interactions.
[19] D. Greenblatt,et al. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[20] C Timchalk,et al. A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[21] R. A. Neal. Studies on the metabolism of diethyl 4-nitrophenyl phosphorothionate (parathion) in vitro. , 1967, The Biochemical journal.
[22] M Sue Marty,et al. The effect of plasma lipids on the pharmacokinetics of chlorpyrifos and the impact on interpretation of blood biomonitoring data. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[23] A. Usmani,et al. Pesticide metabolism in humans, including polymorphisms. , 2005, Scandinavian journal of work, environment & health.
[24] M. Delp,et al. Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.
[25] Charles Timchalk,et al. Comparative inter-species pharmacokinetics of phenoxyacetic acid herbicides and related organic acids. evidence that the dog is not a relevant species for evaluation of human health risk. , 2004, Toxicology.
[26] U. Hofmann,et al. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. , 2001, Pharmacogenetics.
[27] A. Tward,et al. Expression of human paraoxonase (PON1) during development. , 2003, Pharmacogenetics.
[28] Ronald N. Hines,et al. Developmental Expression of the Major Human Hepatic CYP3A Enzymes , 2003, Journal of Pharmacology and Experimental Therapeutics.
[29] C Timchalk,et al. Monte Carlo analysis of the human chlorpyrifos-oxonase (PON1) polymorphism using a physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model. , 2002, Toxicology letters.
[30] M. Schwab,et al. Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance. , 2007, Pharmacogenomics.
[31] M. Bartels,et al. The effect of route, vehicle, and divided doses on the pharmacokinetics of chlorpyrifos and its metabolite trichloropyridinol in neonatal Sprague-Dawley rats. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[32] C. Dary,et al. Physicochemical and Biological Data for the Development of Predictive Organophosphorus Pesticide QSARs and PBPK/PD Models for Human Risk Assessment , 2004, Critical reviews in toxicology.
[33] S. D. Murphy,et al. Kinetic analyses of the microsomal biotransformation of the phosphorothioate insecticides chlorpyrifos and parathion. , 1983, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[34] Sean M Hays,et al. Cholinesterase inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary TCPy , 2009, Journal of Exposure Science and Environmental Epidemiology.
[35] A. Povey. Gene-environmental interactions and organophosphate toxicity. , 2010, Toxicology.
[36] P. Kostyniak,et al. Human Hepatic Cytochrome P450-Specific Metabolism of Parathion and Chlorpyrifos , 2007, Drug Metabolism and Disposition.
[37] R. Fenske,et al. Biomarkers of Chlorpyrifos Exposure and Effect in Egyptian Cotton Field Workers , 2011, Environmental health perspectives.
[38] Tim Morris,et al. Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.
[39] C. Vidair. Age dependence of organophosphate and carbamate neurotoxicity in the postnatal rat: extrapolation to the human. , 2004, Toxicology and applied pharmacology.
[40] J. Albers,et al. Paraoxonase status and plasma butyrylcholinesterase activity in chlorpyrifos manufacturing workers , 2010, Journal of Exposure Science and Environmental Epidemiology.
[41] M. Moran,et al. Sensitive method for the determination of organophosphorus pesticides in fruits and surface waters by high-performance liquid chromatography with ultraviolet detection , 1992 .
[42] Kannan Krishnan,et al. CHARACTERIZATION OF AGE-RELATED CHANGES IN BODY WEIGHT AND ORGAN WEIGHTS FROM BIRTH TO ADOLESCENCE IN HUMANS , 2001, Journal of toxicology and environmental health. Part A.
[43] J W Fisher,et al. In vitro to in vivo extrapolation for trichloroethylene metabolism in humans. , 1998, Toxicology and applied pharmacology.
[44] S. Ekins,et al. Further characterization of the expression in liver and catalytic activity of CYP2B6. , 1998, The Journal of pharmacology and experimental therapeutics.
[45] A. Tward,et al. Paraoxonase 1 (PON1) status and risk of insecticide exposure , 2005, Journal of biochemical and molecular toxicology.
[46] T. Parrón,et al. Paraoxonase activity and genetic polymorphisms in greenhouse workers with long term pesticide exposure , 2003, Human & experimental toxicology.
[47] L G Sultatos,et al. Mammalian toxicology of organophosphorus pesticides. , 1994, Journal of toxicology and environmental health.
[48] S. Wrighton,et al. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). , 1990, Molecular pharmacology.
[49] C. Pope,et al. Carboxylesterase and A-esterase activities during maturation and aging: relationship to the toxicity of chlorpyrifos and parathion in rats. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[50] Richard A Fenske,et al. Chlorpyrifos exposures in Egyptian cotton field workers. , 2010, Neurotoxicology.
[51] A. Rettie,et al. Developmental Expression of Human Hepatic CYP2C9 and CYP2C19 , 2004, Journal of Pharmacology and Experimental Therapeutics.
[52] D. Stresser,et al. Monospecific antipeptide antibody to cytochrome P-450 2B6. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[53] G R Wilkinson,et al. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. , 1994, The Journal of biological chemistry.
[54] J. Lipscomb,et al. Covariation of Human Microsomal Protein Per Gram of Liver with Age: Absence of Influence of Operator and Sample Storage May Justify Interlaboratory Data Pooling , 2008, Drug Metabolism and Disposition.
[55] Jordan N. Smith,et al. Effect of in vivo nicotine exposure on chlorpyrifos pharmacokinetics and pharmacodynamics in rats. , 2010, Chemico-biological interactions.
[56] N. Božina,et al. Genetic Polymorphism of Metabolic Enzymes P450 (CYP) as a Susceptibility Factor for Drug Response, Toxicity, and Cancer Risk , 2009, Arhiv za higijenu rada i toksikologiju.
[57] F. Guengerich,et al. Expression of human cytochrome P450 2B6 in Escherichia coli: characterization of catalytic activity and expression levels in human liver. , 2000, Archives of biochemistry and biophysics.
[58] John C Lipscomb,et al. Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. , 2007, Current drug metabolism.
[59] J. Deddens,et al. Determinants of chlorpyrifos exposures and urinary 3,5,6-trichloro-2-pyridinol levels among termiticide applicators. , 2001, The Annals of occupational hygiene.